Stay updated with breaking news from Analyst Certification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Source: Joe Reagor 05/16/2024 If these cash distributions continue, as expected, the company may consider paying a dividend by year-end 2024, noted Roth MKM.
Source: Joe Reagor 03/29/2024 The figures in totality equate to a US$1.48 billion after-tax net present value at current spot prices, noted a ROTH MKM report.
Follow-up Results From T2 Diabetes Trial Positive
Target Price on Texas-Based Drug Co. Implies 1,929% ROI
Biotech Improves Efficiency of Its New Immunotherapy